To determine whether the protein levels of enzymes of the NAD+ biosynthetic pathway are reduced in PD patient brain, we determined the amounts of NMNATs and SARM1 proteins in the caudate nucleus of NDC and PD subjects. This evidence concerns the gene SARM1 and Parkinson disease.